Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial.
J Cardiovasc Pharmacol Ther
; 24(6): 534-541, 2019 11.
Article
en En
| MEDLINE
| ID: mdl-31131629
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
1-Alquil-2-acetilglicerofosfocolina Esterasa
/
Dislipidemias
/
HDL-Colesterol
/
Hipolipemiantes
/
Niacina
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Cardiovasc Pharmacol Ther
Asunto de la revista:
ANGIOLOGIA
/
CARDIOLOGIA
/
FARMACOLOGIA
Año:
2019
Tipo del documento:
Article